Sign in
Taking people in United StatesNo phase

Gene testing during routine care to guide medicine choices

Checks patients' genes for medicine reactions and tracks whether doctors use the results.

Key facts

Who runs it
University of Chicago
Where
Chicago, United StatesSee the site
Trial code
Registry title
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Status
Recruiting
People taking part
1,200 people, planned
Started
14 Jan 2011
Expected to end
14 Dec 2027
Type of study
Observational
Record updated
4 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults getting ongoing outpatient care at the University of Chicago Medical Center. They give a DNA sample to test genes that may affect how medicines work.

Age
18 years or older.
Sex
All sexes can join.
Disease stage
People must be expected to live at least 3 years. People with heart disease needing specialist care, inflammatory bowel disease, autoimmune or inflammatory disease, long-term blood thinners, hepatitis C or cancer that has not spread are especially sought.
Earlier treatment
People must take at least 1 but not more than 6 prescription medicines now, OR be 65 years or older, OR be likely to need a prescription medicine within the next 5 years.

Main reasons for not taking part

  • A disease likely to cause death within the next 3 years.
  • Had a liver or kidney transplant, or being considered for one.
  • Unable to understand and give informed consent.
  • Not under the routine care of a physician taking part in this trial.

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Receiving ongoing, out-patient care at the University of Chicago Medical Center under the routine care of a physician participating in this trial
  • Life expectancy of at least 3 years
  • Must be 18 years or older
  • Must be taking at least 1 (but not more than 6) prescription medications at the time of enrollment OR be 65 years or older OR be reasonably expected to require the use of a prescription medication within the next 5 years
  • Patients with certain diseases, or likely to receive or be receiving certain drugs, will be targeted particularly for enrollment in order to enrich the study for patients likely to have pharmacogenetically relevant interactions, including, but not limited to:; Patients requiring specialized cardiology care; Patients with inflammatory bowel diseases; Patients with systemic autoimmune or inflammatory diseases; Patients requiring long-term oral anticoagulation; Patients with hepatitis C; Patients with non-metastatic cancer

Who cannot take part

  • Patients who have undergone, or are being actively considered for, liver or kidney transplantation
  • Patients with acute or chronic disease which could be reasonably expected to result in the patient's death within the next 3 years
  • Inability to understand and give informed consent to participate

Where in United States

  • University of Chicago Medical CenterChicago, United StatesContact: 1200 Patients Project Study TeamTaking people

About the trial

What the trial wants to find out

The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.

The group in the trial

  • Adult Patients

    Adults receiving health care at the University of Chicago Medical Center.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Plain-language title
Gene testing during routine care to guide medicine choicesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
4 March 2026